HULIX | VIVIX | HULIX / VIVIX | |
Total Expense Ratio | 1.40 | 0.04 | 3,500% |
Annual Report Gross Expense Ratio | 1.43 | 0.04 | 3,575% |
Fund Existence | 18 years | 27 years | - |
Gain YTD | 5.771 | 6.533 | 88% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 418M | 196B | 0% |
Annual Yield % from dividends | 0.90 | 2.19 | 41% |
Returns for 1 year | 9.65 | 7.91 | 122% |
Returns for 3 years | 38.85 | 25.93 | 150% |
Returns for 5 years | 105.96 | 68.54 | 155% |
Returns for 10 years | 177.84 | 114.61 | 155% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HELX | 29.58 | 0.21 | +0.73% |
Franklin Genomic Advancements ETF | |||
FTGC | 24.88 | 0.10 | +0.40% |
First Trust Global Tact Cmdty Strat ETF | |||
BPH | 53.18 | 0.21 | +0.39% |
BP PLC ADRHEDGED BPH | |||
FAAR | 28.92 | 0.02 | +0.06% |
First Trust Alt Abs Ret Strat ETF | |||
GVUS | 50.89 | -0.16 | -0.31% |
Goldman Sachs MktBt Russell LgCpValEqETF |